Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share
-
Shares outstanding
-
266,212,950
-
Total 13F shares
-
22,274,704
-
Share change
-
+9,686,218
-
Total reported value
-
$127,628,939
-
Price per share
-
$5.73
-
Number of holders
-
57
-
Value change
-
+$52,994,695
-
Number of buys
-
37
-
Number of sells
-
14
Institutional Holders of Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) as of Q1 2021
As of 31 Mar 2021,
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,274,704 shares.
The largest 10 holders included
Capital World Investors, Polygon Management Ltd., Capital International Investors, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Opaleye Management Inc., FMR LLC, SCHRODER INVESTMENT MANAGEMENT GROUP, Ikarian Capital, LLC, Alphabet Inc., and JPMORGAN CHASE & CO.
This page lists
58
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.